Propensity Score–Matched External Controls in Rare Disease Trials: A Promising Tool Requiring Rigorous Validation
Journal of Clinical Oncology · 20.07.2026 · 44 (21) · 1962-1965
DOI: 10.1200/jco-26-00816 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.07.2026. Verfasst von Emily C Zabor. Beteiligte Einrichtung: Department of Quantitative Health Sciences, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Quantitative Health Sciences, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH.
ORCID-Profile: Emily C Zabor
Zitieren
APA
Zabor, E. C. (2026). Propensity Score–Matched External Controls in Rare Disease Trials: A Promising Tool Requiring Rigorous Validation. Journal of Clinical Oncology, 44(21), 1962-1965. https://doi.org/10.1200/jco-26-00816
Vancouver
Zabor EC. Propensity Score–Matched External Controls in Rare Disease Trials: A Promising Tool Requiring Rigorous Validation. Journal of Clinical Oncology. 2026;44(21):1962-1965. doi:10.1200/jco-26-00816
BibTeX
@article{Zabor2026,
author = {Zabor, Emily C},
title = {Propensity Score–Matched External Controls in Rare Disease Trials: A Promising Tool Requiring Rigorous Validation},
journal = {Journal of Clinical Oncology},
year = {2026},
volume = {44},
number = {21},
pages = {1962--1965},
doi = {10.1200/jco-26-00816}
}
EUVIMED